Background: The age of onset of vitiligo is before 20 years in approximately in 50% of patients, and its incidence decreases with increasing age. In this study, our aim was to analyze the epidemiological and clinical factors of patients with late-onset vitiligo and compare these to patients with early-onset vitiligo. Methods: Eight hundred and twenty-five consecutive patients with vitiligo were examined from March 2003 through May 2006. The patients were divided into late-onset (disease onset > 50 years of age) and early-onset groups. Results: There were 54 (6.5%) patients diagnosed with late-onset vitiligo; 48.1% of these patients were female. Of those with early-onset vitiligo, 63.9% were female and 36.1% were male (p ¼ 0.02). Positive family history was present in 27.8% and 40.4% of the late-and early-onset groups, respectively. The most common first sites of involvement were the limbs in both groups. Generalized vitiligo (vitiligo vulgaris) was the most common presentation in both groups. Koebner phenomenon was detected in 79.6% of lateand 64.9% of early-onset vitiligo patients (p ¼ 0.02). Leukotrichia was present in 77.8% of late-and 52.7% of patients with early-onset vitiligo (p < 0.001). Mucosal involvement was observed in 59.3% and 47% of late-and early-onset vitiligo patients, respectively (p ¼ 0.08). Associated diseases were seen in 18.5% of late-and in 23.1% of early-onset vitiligo patients. Conclusion: In patients with late-onset vitiligo, male gender, Koebner phenomenon, leukotrichia, and mucosal involvement were more common than in patients with early-onset vitiligo.
Introduction
Vitiligo is an acquired depigmentation disease that affects 1e2% of the general population without any racial, sexual, or regional predominances. 1e6 It is characterized by white macules, patches of skin, and hair that result from the selective loss of melanocytes. Although vitiligo is generally considered a cosmetic problem, its effect on the psychosocial well-being of patients should not be neglected. 7, 8 There are four main patterns of presentation including common generalized, localized, acrofacial, and segmental. 9 The etiology of this disease is still unknown; however, autoimmune and neurogenic factors have been implicated. Self-destruction of melanocytes by melanin precursors is also thought to play a role in the pathogenesis of vitiligo. Besides these, other factors such as oxidative stress, nitric oxide, and the changes in the monoaminergic system have been suggested. 10e12 Vitiligo usually develops in childhood or young adulthood. 13e16 Approximately 50% of those with vitiligo acquire the disease before the age of 20 years, and the incidence decreases with increasing age. 17 Apart from one study on 182 patients from India, to the best of our knowledge there are no published data on the worldwide epidemiology of late-onset vitiligo. 18 However, that study was just a descriptive study on late-onset vitiligo and no comparisons were made between late-and early-onset vitiligo. Considering the extent of disease burden and the paucity of published information on this subject, the aim of the present study was to analyze and report the epidemiological and clinical features of patients with late-onset vitiligo and compare them to patients with early-onset vitiligo.
Materials and methods
In this cross-sectional study, which was performed from March 2003 to May 2006, 45,910 new patients were referred to the Dermatological Outpatient Department of Afzalipour Hospital, the main referral center of Kerman province in Iran. Of these new patients, 825 patients (1.8%) were diagnosed with vitiligo based on a clinical examination. This study was approved by the review board and ethics committee of Kerman University of Medical Sciences. Written informed consent was obtained each participating patient. Skin biopsies, histopathological studies (FontanaMasson stain), and Wood's lamp examination were performed to diagnose uncertain cases and exclude other diagnoses such as pityriasis alba, guttate hypomelanosis, or postinflammatory hypopigmentation. Tinea versicolor was excluded mostly by Wood's lamp examination and, if necessary, by the examination of skin scrapings. Questionnaires were completed by an expert dermatologist to determine sex, age, duration of disease, clinical patterns, age of onset, Koebner phenomenon, leukotrichia, initial site of disease, family history, mucosal involvement, halo nevus, and associated diseases. Associated diseases were determined by reviewing each patient's medical history and performing a physical examination and, in uncertain cases, by performing related laboratory tests. The vitiligo patients were divided into late-and earlyonset groups according to age of vitiligo onset. Those with vitiligo onset after 50 years of age were categorized as late-onset vitiligo. 18 Family history of vitiligo was obtained by determining the incidence of vitiligo in each patient's immediate family members through fourth-degree relatives. Patients were broadly categorized as having segmental or nonsegmental vitiligo. Segmental vitiligo was considered when there was evidence of dermatomal distribution. Nonsegmental vitiligo was defined as all other types of vitiligo, such as localized, generalized, mucosal, acrofacial, and universal. Localized vitiligo was defined as discrete patches that were confined to one particular area of the body without segmental distribution.
Statistical analysis
Data are presented as the means and standard deviations (SD) of the quantitative variables and absolute and relative frequencies of the categorical variables. In order to compare the two groups, the Student t test (for continuous data) and Chi-square test (for categorical data) were used and, if necessary, the Fisher exact test was used. All statistical analyses were performed using SPSS (version 15; Chicago, IL, USA). A p value < 0.05 was considered statistically significant.
Results
Of the 45,910 new patients who were referred to the dermatological outpatient department over the period of 3 years, 832 received a primary diagnosis of vitiligo. Seven cases suspected of being vitiligo were excluded following skin biopsy and Wood's lamp testing: four were diagnosed with pityriasis alba, two with postinflammatory hypopigmentation, and one with idiopathic guttate hypomelanosis. In the end, 825 cases were diagnosed with vitiligo (1.8%). Of these patients with vitiligo, 54 (6.5%) patients were diagnosed with late-onset vitiligo (> 50 years of age) and 771 (93.5%) were diagnosed with early-onset vitiligo. The clinical features of late-and early-onset vitiligo are shown in Table 1 . Of the 54 patients with late-onset vitiligo, 26 (48.1%) were female and 28 (51.9%) were male. Of those with early-onset vitiligo, 63.9% were female and 36.1% were male (p ¼ 0.02).
Disease duration at the time of diagnosis ranged from 1 month to 20 years in the late-onset group and 2 months to 18 years in the early-onset group. The age distribution of the patients in late-onset group is shown in Table 2 . Forty-one (76%) patients developed vitiligo between the ages of 50e60 years and the rest of these patients developed vitiligo after 60 years of age. The mean age of disease onset was 56.57 AE 7.05 years, and the mean age of the patients at the time of referral was 60.02 AE 8.17 years in the late-onset group. The mean age of the patients in the early-onset group at the time of referral was 24.2 AE 14.04 years (1e80 years). Positive family history was verified in 27.8% and 40.4% of the late-and early-onset patients, respectively, which was not statistically significant.
The most common first site of involvement was the limbs (upper and lower), which was observed in 31 patients (57.4%), followed by the head and neck in 17 patients (31.5%) and the trunk in six (11.1%) patients with late-onset vitiligo. In patients with early-onset vitiligo, the limbs were the most common (50%) first site of involvement followed by the head and neck (33%) and trunk (17%). The clinical types of vitiligo that were observed in our patients are shown in Table 3 . Generalized vitiligo (vitiligo vulgaris) was the most common type in both groups. The universal (p ¼ 0.01) and localized (p ¼ 0.048) types were more common in the late-onset group than the early-onset group. Koebner phenomenon (isomorphic) was observed in 43 (79.6%) late-and 500 (64.9%) early-onset vitiligo patients (p ¼ 0.02). Leukotrichia was present in vitiligo lesions involving hair-bearing areas in 77.8% of late-onset vitiligo patients and in 52.7% of early-onset vitiligo patients (p < 0.001). The pure mucosal type of vitiligo was not detected, but associated mucosal involvement with other clinical variants (generalized or acrofacial; Figure 1 ) was observed in 59.3% and 47% of the late-and early-onset vitiligo patients, respectively (p ¼ 0.08).
Of the 28 patients with mucosal involvement in the late-onset group, genital mucosal involvement was noted in three patients and oral mucosal involvement was noted in 25 patients. Halo nevus was present in one patient (1.9%) with late-onset vitiligo and 10 patients (1.3%) with early-onset vitiligo. Associated disorders were observed in 10 patients (18.5%) with late-onset vitiligo and in 178 patients (23.1%) with early-onset vitiligo. Diabetes mellitus was present in six (11.1%) patients, hypothyroidism in one (1.9%), alopecia areata in two (3.7%), and lichen planus in one (1.9%) patient with late-onset vitiligo. Among the early-onset vitiligo patients, diabetes mellitus was present in 100 patients (13%), hypothyroidism in 20 (2.6%), alopecia areata in 40 (5.2%), and lichen planus in 18 (2.3%). There was no statistically significant difference between early-and late-onset vitiligo in terms of the frequencies of the associated disorders.
Discussion
There are few studies on the epidemiology of vitiligo, and only one study 18 has been published on late-onset vitiligo. Vitiligo is the most common depigmentation disease and affects 1e2% of the population. 19 In most cases, vitiligo develops early in life, and different ages of onset have been reported in various studies. Some studies have reported mean ages of onset for vitiligo that vary between 4e8 years 14e17 and 4e12 years of age. 15e20 Of 825 new cases of vitiligo that were included in the present study, 54 patients (6.5%) claimed onset occurred after 50 years of age. The most common clinical type of late-onset vitiligo was vitiligo vulgaris (generalized type) followed by acrofacial, localized (focal), universal, and segmental. In their study on 182 patients with lateonset vitiligo, Dogra et al reported vitiligo vulgaris as the most common clinical type followed by focal, segmental, acrofacial, pure mucosal, and universal. 18 The clinical features reported in the study by Dogra et al are compared with our study in Table 4 . As in the study by Dogra et al, the study by Liu et al also reported vitiligo vulgaris as the most common clinical type. 6, 18 Focal vitiligo was the second most common presentation of vitiligo among the patients in the study by Dogra et al, but the acrofacial type was the second most common type in the present study among patients with lateonset vitiligo. The segmental and universal types were the least common types seen in our study. Segmental vitiligo generally affects children and young patients and is a significantly large subgroup (19.4e32.5%) within cases of childhood vitiligo. 13, 14, 20, 21 In the study by Dogra et al, the pure mucosal and universal types were the least common. The pure mucosal type of vitiligo was not observed in our patients, but mucosal involvement in association with other clinical variants was seen in our patients with late-onset vitiligo and was significantly more common than in the early-onset group. It is worth noting that no comparisons were made with an early-onset group in the study by Dogra et al. Differences in the proportions of clinical types of vitiligo between different studies may be due to racial or genetic factors unique to those areas and populations; some hitherto unidentified environmental factors may also play a role. The limbs were the most common first site of involvement in our patients. However in the study by Dogra et al, the head and neck was the most common early site of involvement. A higher degree of positive family history (immediate family members through fourth-degree relatives) was present in our patients with late-onset vitiligo (27.8%) compared with the late-onset vitiligo patients reported by Dogra et al. 18 However, in our study, there was no statistically significant differences in terms of family history between the late-and early-onset groups. This difference with the study by Dogra et al may be due to patient selection (first through second-degree relatives and first through fourth-degree relatives were examined in the study by Dogra et al and our study, respectively), the number of enrolled patients, and racial and genetic factors. Leukotrichia was observed in 77.8% of late-onset vitiligo patients; the most common variant was vitiligo vulgaris (55.5%), and this incidence was significantly higher than that observed in the earlyonset group of our study. The rate of leukotrichia was also higher than that observed in the study by Dogra et al: 77.8% compared with 47.3%, respectively. More patients with late-onset vitiligo presented with Koebner phenomenon (79.6%) compared with the study by Dogra. 15, 19 Racial, genetic, solar, and other unknown environmental factors may be involved in the higher incidence of leukotrichia and Koebner phenomenon observed in our study. Vitiligo was associated with other autoimmune diseases in 18.5% of the subjects with late-onset and 23.1% of patients with early-onset, which was not statistically significant. In the study by Dogra et al on late-onset vitiligo, autoimmune disorders were present in 21.4% of patients. Diabetes mellitus was present in 11.0% of our late-onset patients and in 14.8% 18 22 in the Iranian population and may require further study. Hypothyroidism was present in 1.8% of our late-onset group and 8.2% of the patients in the study by Dogra et al, but the incidence of thyroid disease in vitiligo patients has been reported to vary from 0.6e30% in other studies. 1, 5, 6, 10, 19, 23 Although the prevalence of hypothyroidism has not been extensively investigated, the prevalence of hypothyroidism in a nongoitrous population was reported to be 6.4% in one study, which is higher than the findings of this study. 24 This difference may be due to the small number of patients, race, criteria used to screen our patients, and other unknown factors.
The main limitation of this study is that none of the patients underwent laboratory testing to detect associated diseases and we only relied on patient medical histories and physical examinations to make our diagnoses. We used laboratory tests only to verify those with uncertain medical histories and physical examinations. In addition, we did not perform follow-up examinations on our patients, which should be emphasized in future studies.
Conclusion
Here, we present our data on the epidemiological and clinical aspects of late-onset vitiligo (defined as disease onset after 50 years of age) in comparison with early-onset vitiligo. Late-onset vitiligo was rare in this study, only presenting in 6.5% of vitiligo patients. The peak age of disease onset was between 50e60 years of age. The female-to-male ratio was significantly higher among patients with early-onset vitiligo than late-onset. There was also a higher frequency of Koebner phenomenon, leukotrichia, and mucosal involvement among patients with lateonset vitiligo than early-onset. Although the universal type was significantly more common among patients with late-onset vitiligo than those with early-onset vitiligo, the number of patients with this type of vitiligo was small in both groups, making it difficult to come in to a clear conclusion about its significance.
